A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and tax-expressing human T lymphocytes

Retrovirology

Volumn 2, Issue , 2005, Pages

  Escoffier, Emmanuelle ^a   Rezza, Amélie ^a   de Climens, Aude Roborel ^b   Belleville, Aurélie ^b   Gazzolo, Louis ^a   Gilson, Eric ^b   Dodon, Madeleine Duc ^a  

^a UNIVERSITÉ DE LYON   (France)

^b University Lyon i   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; MESSENGER RNA; PROTEIN POT1; TAX PROTEIN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2; UNCLASSIFIED DRUG; POT1 PROTEIN, HUMAN; TELOMERE BINDING PROTEIN;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENZYME ACTIVITY; ENZYME MECHANISM; GENETIC CODE; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PREDICTION; PROTEIN EXPRESSION; T LYMPHOCYTE; TELOMERE; UPREGULATION; VIRUS TRANSFORMATION; CELL LINE; GENETIC TRANSCRIPTION; GENETICS; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOGENICITY; VIROLOGY;

HUMAN T-LYMPHOTROPIC VIRUS 1; LEUKEMIA VIRUS;

CELL LINE; DNA-BINDING PROTEINS; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TELOMERASE; TELOMERE-BINDING PROTEINS; TELOMERIC REPEAT BINDING PROTEIN 1; TELOMERIC REPEAT BINDING PROTEIN 2; TRANSCRIPTION, GENETIC;

EID: 29544444931     PISSN: 17424690     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-2-77     Document Type: Article

References (52)

1. de Lange T, Shiue L, Myers RM, Cox DR, Naylor SL, Killery AM, Varmus HE: Structure and variability of human chromosome ends. Mol Cell Biol 1990, 10:518-527.
2. de Lange T: Protection of mammalian telomeres. Oncogene 2002, 21:532-540.
3. de Lange T: Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005, 19:2100-2110.
4. Cong YS, Wright WE, Shay JW: Human telomerase and its regulation. Microbiol Mol Biol Rev 2002, 66:407-425.
5. Blackburn EH: Switching and signaling at the telomere. Cell 2001, 106:661-673.
6. Loayza D, De Lange T: POT1 as a terminal transducer of TRF1 telomere length control. Nature 2003, 423:1013-1018.
7. Broccoli D, Smogorzewska A, Chong L, de Lange T: Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet 1997, 17:231-235.
8. Bilaud T, Brun C, Ancelin K, Koering CE, Laroche T, Gilson E: Telomeric localization of TRF2, a novel human telobox protein. Nat Genet 1997, 17:236-239.
9. Ancelin K, Brunori M, Bauwens S, Koering CE, Brun C, Ricoul M, Pommier JP, Sabatier L, Gilson E: Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2. Mol Cell Biol 2002, 22:3474-3487.
10. Karlseder J, Smogorzewska A, de Lange T: Senescence induced by altered telomere state, not telomere loss. Science 2002, 295:2446-2449.
11. Wang RC, Smogorzewska A, de Lange T: Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 2004, 119:355-368.
12. Houghtaling BR, Cuttonaro L, Chang W, Smith S: A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2. Curr Biol 2004, 14:1621-1631.
13. Gonzalez-Suarez E, Samper E, Ramirez A, Flores JM, Martin-Caballero J, Jorcano JL, Blasco MA: Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. Embo J 2001, 20:2619-2630.
14. Gonzalez-Suarez E, Samper E, Flores JM, Blasco MA: Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet 2000, 26:114-117.
15. Greenberg RA, Chin L, Femino A, Lee KH, Gottlieb GJ, Singer RH, Greider CW, DePinho RA: Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell 1999, 97:515-525.
16. Artandi SE, Alson S, Tietze MK, Sharpless NE, Ye S, Greenberg RA, Castrillon DH, Horner JW, Weiler SR, Carrasco RD, et al.: Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci U S A 2002, 99:8191-8196.
17. Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, Kurachi A, Beijersbergen RL, Knoll JH, Meyerson M, Weinberg RA: Inhibition of telomerase limits the growth of human cancer cells. Nat Med 1999, 5:1164-1170.
18. Dong CK, Masutomi K, Hahn WC: Telomerase: regulation, function and transformation. Crit Rev Oncol Hematol 2005, 54:85-93.
19. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, Weinberg RA: Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 2001, 15:50-65.
20. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2015.
21. Rudolph KL, Millard M, Bosenberg MW, DePinho RA: Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet 2001, 28:155-159.
22. Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, Greider CW, DePinho RA: p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999, 97:527-538.
23. Artandi SE, DePinho RA: A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr Opin Genet Dev 2000, 10:39-46.
24. O'Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, Emerson S, Emond MJ, Gollahon KA, Moskovitz AH, Crispin A, et al.: Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet 2002, 32:280-284.
25. Zhang A, Wang J, Zheng B, Fang X, Angstrom T, Liu C, Li X, Erlandsson F, Bjorkholm M, Nordenskjord M, et al.: Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix. Oncogene 2004, 23:7441-7447.
26. Chin K, de Solorzano CO, Knowles D, Jones A, Chou W, Rodriguez EG, Kuo WL, Ljung BM, Chew K, Myambo K, et al.: In situ analyses of genome instability in breast cancer. Nat Genet 2004, 36:984-988.
27. Brunori M, Mathieu N, Ricoul M, Bauwens S, Koering CE, Roborel de Climens A, Belleville A, Wang Q, Puisieux I, Decimo D, et al.: TRF2 inhibition promotes anchorage-independent growth of telomerase-positive human fibroblasts. Oncogene 2006, in press.
28. Matsuoka M: Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene. 2003, 22:5131-5140.
29. Mortreux F, Gabet AS, Wattel E: Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia 2003, 17:26-38.
30. Sinha-Datta U, Horikawa I, Michishita E, Datta A, Sigler-Nicot JC, Brown M, Kazanji M, Barrett JC, Nicot C: Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells. Blood 2004, 104:2523-2531.
31. Tsumuki H, Nakazawa M, Hasunuma T, Kobata T, Kato T, Uchida A, Nishioka K: Infection of synoviocytes with HTLV-I induces telomerase activity. Rheumatol Int 2001, 20:175-179.
32. Uchida N, Otsuka T, Arima F, Shigematsu H, Fukuyama T, Maeda M, Sugio Y, Itoh Y, Niho Y: Correlation of telomerase activity with development and progression of adult T-cell leukemia. Leuk Res 1999, 23:311-316.
33. Kubuki Y, Suzuki M, Sasaki H, Toyama T, Yamashita K, Maeda K, Ido A, Matsuoka H, Okayama A, Nakanishi T, et al.: Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia. Leuk Lymphoma 2005, 46:393-399.
34. Gabet AS, Mortreux F, Charneau P, Riou P, Duc-Dodon M, Wu Y, Jeang KT, Wattel E: Inactivation of hTERT transcription by Tax. Oncogene 2003, 22:3734-3741.
35. Hanon E, Hall S, Taylor GP, Saito M, Davis R, Tanaka Y, Usuku K, Osame M, Weber JN, Bangham CR: Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 2000, 95:1386-1392.
36. Jin DY, Spencer F, Jeang KT: Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 1998, 93:81-91.
37. Hollsberg P: Mechanisms of T-Cell Activation by Human T-Cell Lymphotropic Virus Type I. Microbiol. Mol. Biol. Rev. 1999, 63:308-333.
38. Grassmann R, Berchtold S, Radant I, Alt M, Fleckenstein B, Sodroski JG, Haseltine WA, Ramstedt U: Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J Virol 1992, 66:4570-4575.
39. Gatza ML, Watt JC, Marriott SJ: Cellular Transformation by the HTLV-I Tax Protein, a Jack-of-All-Trades. Oncogene 2003, 22:5141-5149.
40. Liu K, Schoonmaker MM, Levine BL, June CH, Hodes RJ, Weng NP: Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc Natl Acad Sci U S A 1999, 96:5147-5152.
41. Hodes RJ, Hathcock KS, Weng NP: Telomeres in T and B cells. Nat Rev Immunol 2002, 2:699-706.
42. Roth A, Yssel H, Pene J, Chavez EA, Schertzer M, Lansdorp PM, Spits H, Luiten RM: Telomerase levels control the lifespan of human T lymphocytes. Blood 2003, 102:849-857.
43. Shay JW, Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 1997, 33:787-791.
44. Smith LL, Coller HA, Roberts JM: Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 2003, 5:474-479.
45. Popovic M, Lange-Wantzin G, Sarin PS, Mann D, Gallo RC: Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus. Proc Natl Acad Sci U S A 1983, 80:5402-546.
46. Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata K, Hinuma Y: Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 1981, 294:770-771.
47. Poiesz BJ, Ruscetti FW, Mier JW, Woods AM, Gallo RC: T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor. Proc Natl Acad Sci USA 1980, 77:6815-6819.
48. Salahuddin SZ, Markham PD, Wong-Staal F, Franchini G, Kalyanaraman VS, Gallo RC: Restricted expression of human T-cell leukemia - lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 1983, 129:51-64.
49. Mori N, Fujii M, Iwai K, Ikeda S, Yamasaki Y, Hata T, Yamada Y, Tanaka Y, Tomonaga M, Yamamoto N: Constitutive activation of transcription factor AP-1 in primary adult T-cell leukemia cells. Blood 2000, 95:3915-3921.
50. Chung HK, Young HA, Goon PK, Heidecker G, Princler GL, Shimozato O, Taylor GP, Bangham CR, Derse D: Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines. Blood 2003, 102:4130-4136.
51. Lemasson I, Robert-Hebmann V, Hamaia S, Duc Dodon M, Gazzolo L, Devaux C: Transrepression of lck gene expression by human T-cell leukemia virus type 1-encoded p40tax. J Virol 1997, 71:1975-1983.
52. Salmon P, Kindler V, Ducrey O, Chapuis B, Zubler RH, Trono D: High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. Blood 2000, 96:3392-3398.